Novo Nordisk: seasonality, event history and insights
In October, Novo Nordisk has averaged +0.30% and risen in 56% of 25 years (2001 to 2025). We rate the October pattern as no clear pattern.
Last close 245.55 on October 6, 2026: -0.51% on the day, -20.91% this year, -3.02% so far in October.
Technicals
| Signal now | Date | Past cases | Avg next 20 sessions | Higher after |
|---|---|---|---|---|
| 50-day crossed below 200-day | Oct 2 | 20 | +1.47% | 55% |
| RSI below 30 | Oct 6 | 25 | +1.96% | 64% |
Month by month
| Month | Average | Median | Up years | Last 10 years | Best | Worst | Years | Pattern |
|---|---|---|---|---|---|---|---|---|
| January | -5.67% | -0.29% | 48% | +1.70% | +15.31% | -54.76% | 25 | no clear pattern |
| February | +2.90% | +4.90% | 73% | -1.37% | +17.67% | -35.62% | 26 | moderate |
| March | +2.39% | +1.28% | 62% | +1.13% | +18.09% | -25.89% | 26 | weak |
| April | +1.63% | +2.29% | 73% | +3.90% | +17.91% | -27.76% | 26 | moderate |
| May | +4.43% | +1.95% | 65% | +2.13% | +89.83% | -8.51% | 26 | weak |
| June | +0.40% | +1.67% | 54% | +2.46% | +9.89% | -43.84% | 26 | no clear pattern |
| July | -0.94% | -1.02% | 38% | -2.45% | +10.39% | -28.46% | 26 | weak |
| August | +2.76% | +1.68% | 54% | +5.64% | +28.57% | -16.71% | 26 | no clear pattern |
| September | -1.88% | -1.22% | 38% | -3.39% | +8.88% | -16.13% | 26 | moderate |
| October | +0.30% | +0.92% | 56% | -0.01% | +15.13% | -11.98% | 25 | no clear pattern |
| November | +2.80% | +2.23% | 76% | +2.39% | +11.11% | -3.85% | 25 | strong |
| December | +16.92% | +3.62% | 84% | +0.69% | +111.46% | -17.58% | 25 | strong |
What drives Novo Nordisk
- GLP-1 obesity and diabetes drugs, competition with Eli Lilly and US pricing policy.
- Trial results and supply capacity announcements.
Sell in May for Novo Nordisk
From 2002 to 2025, the November to April half averaged +15.17% and the May to October half +3.67%. The winter half did better in 71% of 24 years. Compare all markets.
Year by year
Latest insights on Novo Nordisk
Questions
What is the best month for Novo Nordisk?
Since 2001, December has had the highest average move for Novo Nordisk at +16.92%, rising in 84% of 25 years. December has the highest share of positive years (84%).
What is the worst month for Novo Nordisk?
January has had the weakest average move at -5.67%, rising in 48% of 25 years.
How does Novo Nordisk usually do in October?
Novo Nordisk has averaged +0.30% in October (median +0.92%), rising in 56% of 25 years. We rate the pattern as no clear pattern.
Alerts for Novo Nordisk
Pick your markets. We email when something relevant moves. Free during launch.
Not investment advice. Market Seasonality publishes historical statistics, news summaries and scenario analysis for information and education. Past patterns do not guarantee future results. Nothing here is a recommendation to buy, sell or hold any asset, and scenarios describe possible paths without predicting them. See the disclaimer and methodology.